Influenza News and Research

Latest Influenza News and Research

New test capable of detecting all viruses that affect people and animals

A new, super-sensitive test has been developed that can detect virtually any virus that causes illness in humans and animals, according to researchers at Washington University School of Medicine in St. Louis.

1 Oct 2015

BiondVax to begin Phase IIb clinical trial of universal influenza vaccine in Europe

BiondVax Pharmaceuticals Ltd. announced today that it received regulatory clearance from the Hungarian Regulatory Authority (National Institute of Pharmacology and Nutrition, OGYEI) and the Central Ethics Committee in Budapest to initiate a Phase IIb clinical trial. The initiation meeting was scheduled for today, September 30, 2015, together with the partners from the UNISEC European Consortium.

30 Sep 2015

New test identifies viruses that infect people and animals

A new test detects virtually any virus that infects people and animals, according to research at Washington University School of Medicine in St. Louis, where the technology was developed.

30 Sep 2015

New study broadens understanding of how the immune system responds to flu virus

A new study of influenza infection in an animal model broadens understanding of how the immune system responds to flu virus, showing that the process is more dynamic than usually described, engaging a broader array of biological pathways. The researchers say their findings may offer key insights for designing more effective vaccines in general.

29 Sep 2015

Specialized proteins can inhibit HIV

There is little doubt that the Human Immunodeficiency Virus, or HIV, is devastating. More than 1.2 million people in the United States are living with HIV and more than 47,000 people are diagnosed annually. Now, University of Missouri researchers have made a discovery in how specialized proteins can inhibit the virus, opening the door for progress in the fight against HIV and for the production of advanced therapeutics to combat the disease.

29 Sep 2015

Teva presents new Reslizumab data at European Respiratory Society (ERS) International Congress 2015

Teva Pharmaceutical Industries Ltd., has presented results from a post hoc analysis of two pivotal Phase III clinical trials showing that treatment with reslizumab reduced clinical asthma exacerbations (CAEs) by 75 percent versus placebo in a subgroup of patients with late onset asthma (diagnosed at 40 years of age and older) with elevated blood eosinophils, who were inadequately controlled on inhaled corticosteroids (ICS).

28 Sep 2015

Soft palate study reveals how flu viruses acquire the ability to move between people

National Institutes of Health scientists and their colleagues identified a previously unappreciated role for the soft palate during research to better understand how influenza (flu) viruses acquire the ability to move efficiently between people.

26 Sep 2015

H7N9 influenza vaccine failure may be due to immune camouflage, study reveals

The avian influenza A (H7N9) virus has been a major concern since the first outbreak in China in 2013. Due to its high rate of lethality and pandemic potential, H7N9 vaccine development has become a priority for public health officials. However, candidate vaccines have failed to elicit the strong immune responses necessary to protect from infection.

25 Sep 2015

Soft palate plays key role in viruses' ability to spread

Flu viruses come in many strains, and some are better equipped than others to spread from person to person. Scientists have now discovered that the soft palate -- the soft tissue at the back of the roof of the mouth -- plays a key role in viruses' ability to travel through the air from one person to another.

24 Sep 2015

Novel mechanism may help explain the virulence of 1918 'Spanish' flu

While yearly outbreaks of flu kill about 250,000 to 500,000 people worldwide, the 1918 "Spanish" flu infected one-third of the world's population and killed 50 million to 100 million. Chad Petit, Ph.D., assistant professor in the University of Alabama at Birmingham Department of Biochemistry and Molecular Genetics, has discovered a novel mechanism for one 1918 flu virus protein that may help explain the virulence of that unusually deadly pandemic.

23 Sep 2015

Optum and AMGF launch pilot collaborative to enhance adult vaccination rates

The American Medical Group Foundation (AMGF) and Optum, with support from Pfizer, are launching a pilot collaborative to improve adult vaccination rates.

23 Sep 2015

WHO and the Government of Saudi Arabia work together to care for health issues of hajj pilgrims

As an estimated 2 million Muslims from 184 countries gather in Saudi Arabia’s holy city of Mecca to take part in the annual hajj pilgrimage, months of preparations to care for health issues of pilgrims are also coming together.

22 Sep 2015

Glide Technologies, Cilian collaborate to develop solid dose formulation of recombinant influenza vaccine

Glide Technologies, the development company focused on solid dose formulations of therapeutics and vaccines, today announced that it has entered a collaboration with German biotechnology company Cilian AG to develop a solid dose formulation of Cilian's experimental recombinant influenza vaccine, CiFlu, for delivery using Glide's patient-friendly SDI delivery device.

21 Sep 2015

UC San Diego, TSRI form new consortium to map cells in space and time

Drawing on complementary strengths of two San Diego institutions, The Scripps Research Institute (TSRI) and the University of California, San Diego (UC San Diego) have formed a new consortium with a big mission: to map cells in space and time.

18 Sep 2015

Experts recommend three simple steps to combat flu

Experts at the National Foundation for Infectious Diseases Influenza/Pneumococcal news conference today reinforced the important message of prevention this upcoming cold and flu season.

17 Sep 2015

NCOA and award-winning actress Judith Light support national educational initiative, Flu + You

Two-time Emmy and Tony award-winning actress Judith Light and the National Council on Aging (NCOA) are teaming up for the second year on the national educational initiative Flu + You to educate older adults and those who care for them about the seriousness of influenza ("the flu"), the importance of prevention and available vaccine options.

16 Sep 2015

ACP awarded $1,002,884 Cooperative Agreement to increase adult immunization rates in US

The American College of Physicians (ACP) was awarded a $1,002,884 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) to increase immunization rates in the United States.

16 Sep 2015

CureVac announces official launch of U.S. operations in Cambridge, MA

CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announced the official launch of its U.S. operations in Cambridge, MA, as the company advances the development of its proprietary mRNA platform technology and multiple, clinical-stage mRNA therapeutics and vaccines.

10 Sep 2015

Healthy adults who receive flu vaccination may also help protect older adults at higher risk for flu-related complications

Healthy adults who get the flu vaccine may help protect not only themselves but also older adults in their community at higher risk for serious complications from influenza, suggest findings from a new study published in Clinical Infectious Diseases. Based on a national sample of more than 3 million people across eight flu seasons, researchers observed that seniors were up to 21 percent less likely to be diagnosed with flu-related illness if they lived in areas where more adults under 65 were immunized.

10 Sep 2015

NanoPass to supply MicronJet600 device for use with Immune Design's ZVex discovery platform

NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.

8 Sep 2015

Influenza News and Research

Latest Influenza News and Research

New test capable of detecting all viruses that affect people and animals

BiondVax to begin Phase IIb clinical trial of universal influenza vaccine in Europe

New test identifies viruses that infect people and animals

New study broadens understanding of how the immune system responds to flu virus

Specialized proteins can inhibit HIV

Teva presents new Reslizumab data at European Respiratory Society (ERS) International Congress 2015

Soft palate study reveals how flu viruses acquire the ability to move between people

H7N9 influenza vaccine failure may be due to immune camouflage, study reveals

Soft palate plays key role in viruses' ability to spread

Novel mechanism may help explain the virulence of 1918 'Spanish' flu

Optum and AMGF launch pilot collaborative to enhance adult vaccination rates

WHO and the Government of Saudi Arabia work together to care for health issues of hajj pilgrims

Glide Technologies, Cilian collaborate to develop solid dose formulation of recombinant influenza vaccine

UC San Diego, TSRI form new consortium to map cells in space and time

Experts recommend three simple steps to combat flu

NCOA and award-winning actress Judith Light support national educational initiative, Flu + You

ACP awarded $1,002,884 Cooperative Agreement to increase adult immunization rates in US

CureVac announces official launch of U.S. operations in Cambridge, MA

Healthy adults who receive flu vaccination may also help protect older adults at higher risk for flu-related complications

NanoPass to supply MicronJet600 device for use with Immune Design's ZVex discovery platform

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Influenza News and Research

Latest Influenza News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in